Engineering Medicines To Improve Patient Care
Elevating
Therapeutics
We are committed to developing best-in-class therapeutic antibodies to improve patient care.
Learn More
Our Lead Programs
Our therapeutic programs harness groundbreaking clinical discoveries and proven technologies to craft best-in-class monoclonal antibodies.
VRDN-001
Learn MoreAn anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody in development for thyroid eye disease (TED)
VRDN-002
Learn MoreOur second generation product candidate for TED, incorporates half-life extension technology and is intended for subcutaneous administration
Treatments
Targeting
Patient Needs
We are dedicated to creating solutions for patients’ most pressing needs. Learn more about our initial programs for patients sufferring from Thyroid Eye Disease.
Significant
Antibody
Expertise
Viridian Therapeutics is engineering and developing best-in-class antibodies for patients suffering from serious diseases that are underserved by current therapies.
A New Path to Better Medicines
We have reimagined therapeutics research and development, accelerating the transformational benefits biotechnology can offer to patients suffering from serious diseases.
Learn MoreNovel Therapeutics Designed For Impact
Our pipeline of candidate therapeutics reflects a patient-centric model of innovation. We leverage proven biology and technology to efficiently craft medicines to meet the needs of patients and healthcare providers.